Dr. Jhodi Webster’s scientific journey began with a personal tragedy—watching her stepfather’s memory gradually deteriorate following an Alzheimer’s diagnosis. This profoundly painful experience ignited a determination that would ultimately define her career path and research ambitions.
Now a 28-year-old post-doctoral research fellow at Mayo Clinic in Arizona, the Jamaican scientist is conducting cutting-edge research on the very disease that affected her family. Her work focuses on understanding neurodegenerative mechanisms while building connections with patients and caregivers facing similar challenges.
Webster’s academic journey began at St Andrew High School for Girls in Jamaica, where she initially aspired to become a medical doctor. Her stepfather’s early-onset dementia diagnosis, however, redirected her ambitions toward medical research. In 2016, she migrated to the United States on scholarship to pursue neuroscience studies at Agnes Scott College.
Her research examines the intriguing overlap between Alzheimer’s and Parkinson’s diseases—two progressive neurodegenerative disorders with distinct symptoms but shared characteristics of cognitive decline and dementia. Webster’s doctoral work at the University of Alabama at Birmingham involved developing novel animal models that incorporate toxic proteins found in patients’ brains, enabling detailed study of neuroinflammatory responses.
“We’ve demonstrated that when Parkinson’s and Alzheimer’s pathology overlaps in brains, it triggers a distinct immune response not seen in cases with pure protein pathology,” Webster explained. This critical insight opens new therapeutic possibilities targeting both the toxic proteins and inflammatory responses in the brain.
Her research has garnered significant recognition, with numerous presentation awards and scholarships from organizations including the Parkinson’s Association of Alabama. Beyond laboratory work, Webster has prioritized community engagement, connecting with caregivers and patients whose experiences mirror her family’s journey.
“Seeing someone you’ve known for years become a shell of themselves is devastating,” Webster shared. “That personal connection makes this research profoundly meaningful—it’s not just about finding a cure but about connecting with those directly affected.”
At Mayo Clinic, Webster continues her pioneering work, investigating how neuroinflammation contributes to Parkinson’s, Alzheimer’s, and ALS. Her research aims to develop targeted immunotherapies that could modify disease progression rather than merely addressing symptoms.
While acknowledging that a complete cure remains ambitious, Webster remains committed to developing treatments that improve quality of life for neurodegenerative patients. “Patients can live 10-20 years with these diseases, but it’s often with low quality of life,” she noted. “Developing targeted therapies to prevent neuronal death and cognitive decline is my immediate mission.”
Reflecting on her journey from Jamaica to elite medical research, Webster expresses both pride in her accomplishments and gratitude for the mentors who supported her path. Her work stands as a testament to how personal experience can drive scientific innovation and compassion in equal measure.